X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare AANJANEYA LIFECARE with PLETHICO PHARMA - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. DATSONS LABS vs PLETHICO PHARMA - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DR. DATSONS LABS PLETHICO PHARMA DR. DATSONS LABS/
PLETHICO PHARMA
 
P/E (TTM) x -10.9 -1.1 - View Chart
P/BV x 0.2 0.0 968.7% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 DR. DATSONS LABS   PLETHICO PHARMA
EQUITY SHARE DATA
    DR. DATSONS LABS
Mar-14
PLETHICO PHARMA
Mar-14
DR. DATSONS LABS/
PLETHICO PHARMA
5-Yr Chart
Click to enlarge
High Rs126395 31.8%   
Low Rs3131 98.7%   
Sales per share (Unadj.) Rs133.0604.4 22.0%  
Earnings per share (Unadj.) Rs0.232.5 0.5%  
Cash flow per share (Unadj.) Rs6.651.3 12.9%  
Dividends per share (Unadj.) Rs00-  
Dividend yield (eoy) %00-  
Book value per share (Unadj.) Rs128.8473.6 27.2%  
Shares outstanding (eoy) m31.6634.08 92.9%   
Bonus/Rights/Conversions FCCB--  
Price / Sales ratio x0.60.4 166.9%   
Avg P/E ratio x516.16.6 7,866.3%  
P/CF ratio (eoy) x11.84.2 285.2%  
Price / Book Value ratio x0.60.5 135.0%  
Dividend payout %00-   
Avg Mkt Cap Rs m2,4777,262 34.1%   
No. of employees `000NANA-   
Total wages/salary Rs m561,596 3.5%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m4,21120,598 20.4%  
Other income Rs m79386 20.4%   
Total revenues Rs m4,28920,984 20.4%   
Gross profit Rs m5692,818 20.2%  
Depreciation Rs m204642 31.8%   
Interest Rs m4301,593 27.0%   
Profit before tax Rs m13969 1.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m-20-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m6-138 -4.4%   
Profit after tax Rs m51,107 0.4%  
Gross profit margin %13.513.7 98.7%  
Effective tax rate %48.0-14.3 -336.2%   
Net profit margin %0.15.4 2.1%  
BALANCE SHEET DATA
Current assets Rs m6,85218,877 36.3%   
Current liabilities Rs m6,71111,896 56.4%   
Net working cap to sales %3.333.9 9.9%  
Current ratio x1.01.6 64.3%  
Inventory Days Days16136 447.6%  
Debtors Days Days318198 161.0%  
Net fixed assets Rs m3,6739,861 37.2%   
Share capital Rs m317341 92.9%   
"Free" reserves Rs m3,76112,331 30.5%   
Net worth Rs m4,07816,139 25.3%   
Long term debt Rs m1,6714,706 35.5%   
Total assets Rs m12,63333,146 38.1%  
Interest coverage x1.01.6 64.0%   
Debt to equity ratio x0.40.3 140.5%  
Sales to assets ratio x0.30.6 53.6%   
Return on assets %3.48.1 42.3%  
Return on equity %0.16.9 1.7%  
Return on capital %7.712.3 62.4%  
Exports to sales %22.921.4 107.1%   
Imports to sales %14.315.2 93.9%   
Exports (fob) Rs m9644,402 21.9%   
Imports (cif) Rs m6023,136 19.2%   
Fx inflow Rs m9644,402 21.9%   
Fx outflow Rs m6073,184 19.1%   
Net fx Rs m3571,219 29.3%   
CASH FLOW
From Operations Rs m1,3452,437 55.2%  
From Investments Rs m-2,256-6,265 36.0%  
From Financial Activity Rs m-1,2002,490 -48.2%  
Net Cashflow Rs m-2,111-1,337 157.8%  

Share Holding

Indian Promoters % 4.5 82.7 5.5%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 4.3 -  
FIIs % 1.4 5.5 24.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 94.1 7.5 1,254.7%  
Shareholders   20,807 10,665 195.1%  
Pledged promoter(s) holding % 0.0 85.7 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DR. DATSONS LABS With:   IPCA LABS  NOVARTIS  ALEMBIC PHARMA  MERCK LTD  SANOFI INDIA  

Compare DR. DATSONS LABS With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices Continue Sell-Off; Sensex Slumps Over 530 Points(Closing)

Share markets in India continued their sell-off seen during the last week and ended the day deep in the red. All sectoral indices traded on a negative note.

Related Views on News

Hindustan Aeronautics IPO: Yet Another Play on India's Defence Sector (IPO)

Mar 14, 2018

Should you apply for the IPO of state-run military aircraft maker Hindustan Aeronautics?

Bharat Dynamics IPO: Worth Betting on Defence Manufacturing? (IPO)

Mar 12, 2018

Should you apply for the IPO of Bharat Dynamics, India's first state-owned missile manufacturer?

Apollo Micro Systems Ltd. (IPO)

Jan 9, 2018

Should you subscribe to the IPO of Apollo Micro Systems Ltd?

Khadim India Ltd. (IPO)

Oct 31, 2017

Should you subscribe to the IPO of Khadim India Ltd?

Mahindra Logistics Ltd. (IPO)

Oct 28, 2017

Should you subscribe to the IPO of Mahindra Logistics Ltd?

More Views on News

Most Popular

My First Pharma Stock Recommendation!(The 5 Minute Wrapup)

Sep 21, 2018

This company has not only created a niche in the pharma space, it has done so profitably.

Want Bigger Returns Than You Thought Possible? This is Where You Should Look(Profit Hunter)

Sep 12, 2018

Richa has discovered the single most profitable opportunity in the market - read on to discover more...

Are You Blindly Investing In Equities? Read This...(Outside View)

Sep 11, 2018

PersonalFN explains how blindly investing in equities can prove hazardous to your wealth and health.

Investors Are Redeeming From Equity Mutual Funds Now. Should You?(Outside View)

Sep 12, 2018

PersonalFN elucidates if you should redeem from equity mutual fund now, and the approach to follow before you decide to sell mutual funds.

Outperformance of Strong Established Brands in the Indian Stock market(Chart Of The Day)

Sep 14, 2018

Strong Well established Indian Brands have comfortably outperformed the index in the decade post the global financial crisis.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

DR. DATSONS LABS SHARE PRICE


May 21, 2015 (Close)

TRACK DR. DATSONS LABS

  • Track your investment in DR. DATSONS LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DR. DATSONS LABS

DR. DATSONS LABS - ALKEM LABORATORIES COMPARISON

COMPARE DR. DATSONS LABS WITH

MARKET STATS